1. Home
  2. SLRX vs SGLY Comparison

SLRX vs SGLY Comparison

Compare SLRX & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • SGLY
  • Stock Information
  • Founded
  • SLRX N/A
  • SGLY 2001
  • Country
  • SLRX United States
  • SGLY United States
  • Employees
  • SLRX N/A
  • SGLY N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • SLRX Health Care
  • SGLY
  • Exchange
  • SLRX Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • SLRX 3.6M
  • SGLY 3.4M
  • IPO Year
  • SLRX N/A
  • SGLY 2008
  • Fundamental
  • Price
  • SLRX $3.21
  • SGLY $0.59
  • Analyst Decision
  • SLRX
  • SGLY
  • Analyst Count
  • SLRX 0
  • SGLY 0
  • Target Price
  • SLRX N/A
  • SGLY N/A
  • AVG Volume (30 Days)
  • SLRX 197.9K
  • SGLY 235.5K
  • Earning Date
  • SLRX 11-10-2025
  • SGLY 11-14-2025
  • Dividend Yield
  • SLRX N/A
  • SGLY N/A
  • EPS Growth
  • SLRX N/A
  • SGLY N/A
  • EPS
  • SLRX N/A
  • SGLY N/A
  • Revenue
  • SLRX N/A
  • SGLY $1,813,193.00
  • Revenue This Year
  • SLRX N/A
  • SGLY N/A
  • Revenue Next Year
  • SLRX N/A
  • SGLY N/A
  • P/E Ratio
  • SLRX N/A
  • SGLY N/A
  • Revenue Growth
  • SLRX N/A
  • SGLY N/A
  • 52 Week Low
  • SLRX $3.16
  • SGLY $0.54
  • 52 Week High
  • SLRX $108.00
  • SGLY $5.49
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 37.04
  • SGLY 30.42
  • Support Level
  • SLRX $3.55
  • SGLY $0.71
  • Resistance Level
  • SLRX $3.97
  • SGLY $0.64
  • Average True Range (ATR)
  • SLRX 0.31
  • SGLY 0.05
  • MACD
  • SLRX -0.07
  • SGLY -0.00
  • Stochastic Oscillator
  • SLRX 3.72
  • SGLY 2.70

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: